Posted by Michael Wonder on 18 Oct 2017
Drug supply players point a finger everywhere but themselves
18 October 2017 - Lobby groups to go before Senate committee on drug prices.
A day after President Donald Trump renewed his attack on high drug prices, officials from the drug industry’s top lobbying groups sat down at a black cloth-draped table in a Senate hearing room and told lawmakers who’s to blame: the person a few seats over.
Drugmakers said in prepared remarks that insurers, pharmacy-benefit managers and hospitals, among others, keep a large chunk of the money Americans spend on medicine and don’t pass on savings to patients.
